Xiaoting Luo
Impact in
-
- Tryptophan and brain disorders
- Neurology top 10%
- Neuroinflammation and Neurodegeneration Mechanisms
Papers in ⓘ
-
- Single-cell and spatial transcriptomics 2
- Gut microbiota and health 2
- Oncology 6
- CAR-T cell therapy research 2
- Co-authors
- Hongrui Zhan (1 shared paper)Xing‐Mei Zhang (1 shared paper)Yan Lin (1 shared paper)Linhan Wang (1 shared paper)Yanyan Zeng (1 shared paper)Yaping Wang (1 shared paper)Wen Wu (1 shared paper)Fang Wang (1 shared paper)
- Journals
- World Journal of Surgical Oncology (2 papers)European Journal of Medicinal Chemistry (1 paper)Frontiers in Psychiatry (1 paper)Aging (1 paper)Frontiers in Immunology (1 paper)
- Partner nations
- China
In The Last Decade
Xiaoting Luo
24 papers receiving 473 citations
Hit Papers
Peers
Comparison fields: 5 of 82
- Biological Psychiatry 23
- Neurology 72
- Pharmacology 40
- Complementary and alternative medicine 37
- Nephrology 29
Countries citing papers authored by Xiaoting Luo
This map shows the geographic impact of Xiaoting Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoting Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoting Luo more than expected).
Fields of papers citing papers by Xiaoting Luo
This network shows the impact of papers produced by Xiaoting Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoting Luo. The network helps show where Xiaoting Luo may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaoting Luo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 131 | |
| 2 | Hepatocellular carcinoma: signaling pathways, targeted therapy, and immunotherapy Hit paper breakdown → | 2024 | 55 |
| 3 | 2015 | 47 | |
| 4 | 2017 | 35 | |
| 5 | 2019 | 26 | |
| 6 | 2021 | 23 | |
| 7 | 2018 | 21 | |
| 8 | 2024 | 20 | |
| 9 | 2017 | 19 | |
| 10 | 2023 | 15 | |
| 11 | 2022 | 15 | |
| 12 | 2019 | 13 | |
| 13 | 2024 | 9 | |
| 14 | 2023 | 8 | |
| 15 | 2021 | 8 | |
| 16 | 2023 | 6 | |
| 17 | 2019 | 6 | |
| 18 | 2020 | 5 | |
| 19 | 2023 | 4 | |
| 20 | 2023 | 4 |
About Xiaoting Luo
Xiaoting Luo is a scholar working on Molecular Biology, Oncology, Physiology, Pulmonary and Respiratory Medicine and Immunology, having authored 26 papers that have together received 477 indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (4 papers), Tryptophan and brain disorders (3 papers), Cholinesterase and Neurodegenerative Diseases (3 papers), Pharmacological Effects of Natural Compounds (3 papers), Single-cell and spatial transcriptomics (2 papers), CAR-T cell therapy research (2 papers), Ferroptosis and cancer prognosis (2 papers) and Gut microbiota and health (2 papers). The work is most often cited by research in Biological Psychiatry (23 citations), Neurology (72 citations), Pharmacology (40 citations), Complementary and alternative medicine (37 citations) and Nephrology (29 citations). Xiaoting Luo has collaborated with scholars based in China. Frequent co-authors include Hongrui Zhan, Xing‐Mei Zhang, Yan Lin, Linhan Wang, Yanyan Zeng, Yaping Wang, Wen Wu, Fang Wang, Zhenguang Huang and Chunming Wang. Their work appears in journals such as World Journal of Surgical Oncology, European Journal of Medicinal Chemistry, Frontiers in Psychiatry, Aging and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.